Arkolith/Insider Trading/CRNX/Form 4

Okey Stephanie

DirectorCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$246K
Net Open-Market Flow
-$246K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Sell(S)6K$35.62$224K7K
Jun 17, 2026Sell(S)608$36.22$22K6K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-044419) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML